NETGEAR Demonstrates the Best of the Connected World for CES 2017
Jan 05, 2017 13:31 pm UTC| Business
LAS VEGAS, Nev., Jan. 05, 2017 -- NETGEAR®, Inc. (NASDAQ:NTGR), the leading provider of networking devices that power today’s smart home and small and medium-sized businesses (SMBs), is introducing a range of new...
Onconova Therapeutics, Inc. to Present Corporate Overview at Biotech Showcase 2017
Jan 05, 2017 13:31 pm UTC| Business
NEWTOWN, Pa., Jan. 05, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that...
Onconova Therapeutics, Inc. to Present Corporate Overview at Biotech Showcase 2017
Jan 05, 2017 13:31 pm UTC| Business
NEWTOWN, Pa., Jan. 05, 2017 -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, today announced that...
Cellectar Biosciences to Present at the 9th Annual Biotech Showcase
Jan 05, 2017 13:31 pm UTC| Business
MADISON, Wis., Jan. 05, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company, announces today that President and CEO, Jim Caruso will present at the Biotech...
Cellectar Biosciences to Present at the 9th Annual Biotech Showcase
Jan 05, 2017 13:31 pm UTC| Business
MADISON, Wis., Jan. 05, 2017 -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, clinical stage biotechnology company, announces today that President and CEO, Jim Caruso will present at the Biotech...
OncoMed Announces Year-End Cash Balance and 2017 Outlook
Jan 05, 2017 13:31 pm UTC| Business
Enters 2017 with $184.6 Million in Cash Potential for Five Program Opt-ins Totaling Over $170M Anti-TIGIT (I/O#2) IND Filed REDWOOD CITY, Calif., Jan. 05, 2017 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a...
OncoMed Announces Year-End Cash Balance and 2017 Outlook
Jan 05, 2017 13:31 pm UTC| Business
Enters 2017 with $184.6 Million in Cash Potential for Five Program Opt-ins Totaling Over $170M Anti-TIGIT (I/O#2) IND Filed REDWOOD CITY, Calif., Jan. 05, 2017 -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a...